Artwork

Content provided by Bloomberg. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bloomberg or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Dave Ricks

22:38
 
Share
 

Manage episode 460208569 series 3390423
Content provided by Bloomberg. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bloomberg or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that's transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see if its weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction. He also discusses how the company is tackling the issue of counterfeit drugs, as well as the other projects they have on the pipeline. This interview was recorded on December 10 at the Economic Club of Washington DC.

See omnystudio.com/listener for privacy information.

  continue reading

123 episodes

Artwork
iconShare
 
Manage episode 460208569 series 3390423
Content provided by Bloomberg. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bloomberg or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that's transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see if its weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction. He also discusses how the company is tackling the issue of counterfeit drugs, as well as the other projects they have on the pipeline. This interview was recorded on December 10 at the Economic Club of Washington DC.

See omnystudio.com/listener for privacy information.

  continue reading

123 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play